Change in body composition of premature infants from parenteral nutrition discontinuation to term equivalent age

Giulia Paviotti1, Angela De Cunto1, Laura Travan1

  • 1Neonatal Intensive Care Unit, Institute for Maternal and Child Health - IRCCS Burlo Garofolo, Trieste, Italy.

Early Human Development
|September 9, 2020
PubMed

Insights

Premature infants showed similar fat-free mass z-scores but increased fat mass and % fat mass z-scores from parenteral nutrition suspension to term-equivalent age. Nutritional intake did not appear to influence this change.

Area of Science:

  • Neonatology
  • Pediatric Nutrition
  • Body Composition Analysis

Background:

  • Premature infants often experience altered growth trajectories.
  • Understanding body composition changes is crucial for long-term health outcomes.
  • Parenteral nutrition (PN) is a common supportive therapy for preterm infants.

Purpose of the Study:

  • To compare the body composition (BC) of premature infants at the suspension of parenteral nutrition (PN) and at term-equivalent age (TEA).
  • To assess changes in fat mass (FM) and fat-free mass (FFM) in preterm infants during the transition from PN to enteral feeding and up to TEA.

Main Methods:

  • Air-displacement plethysmography was used to measure body composition in preterm infants (<32 weeks gestational age).
  • Measurements were taken at PN suspension and again at TEA.
  • Z-scores for BC and anthropometric measurements were calculated and compared.

Main Results:

  • Fat-free mass (FFM) z-scores remained similar between PN suspension and TEA (-1.43 vs -1.78).
  • Fat mass (FM) z-scores and %FM z-scores significantly increased from PN suspension to TEA (FM: 0.23 vs 2.04; %FM: 0.66 vs 2.08).
  • At TEA, preterm infants had similar weight and length but higher %FM compared to term-born infants.

Conclusions:

  • Preterm infants exhibit a significant increase in fat mass and % fat mass from PN suspension to TEA, while FFM remains stable.
  • These changes in body composition occur despite similar weight and length at TEA compared to term-born infants.
  • Nutritional intakes during exclusive enteral nutrition did not appear to drive the observed increase in fat mass.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
168
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
515
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
145
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
108
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
563
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
139